Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndrome

Allogeneic hematopoietic stem cell transplantation (A-HSCT) remains the only curative option for patients with myelodysplastic syndrome (MDS). We used the NUP98-HOXD13 (NHD13) murine model for MDS to study HSCT in a pre-clinical setting. NHD13 recipients transplanted with syngeneic bone marrow (S-HS...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Yang Jo, Fry, Terry J., Aplan, Peter D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617185/
https://www.ncbi.nlm.nih.gov/pubmed/28953912
http://dx.doi.org/10.1371/journal.pone.0185219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617185/
https://www.ncbi.nlm.nih.gov/pubmed/28953912
http://dx.doi.org/10.1371/journal.pone.0185219

Ejemplares similares